Teriparatide
A bone-building drug. A parathyroid-hormone fragment (PTH 1-34), FDA-approved as Forteo for severe osteoporosis. Anabolic for bone, the opposite of bisphosphonates.
Teriparatide: A bone-building drug. A parathyroid-hormone fragment (PTH 1-34), FDA-approved as Forteo for severe osteoporosis. Anabolic for bone, the opposite of bisphosphonates. Teriparatide is the active piece of parathyroid hormone (PTH 1-34).
Teriparatide is the active piece of parathyroid hormone (PTH 1-34). FDA-approved as Forteo for severe osteoporosis. Unlike most osteoporosis drugs, it actually builds new bone instead of just slowing bone loss. Daily injection, capped at 24 months total lifetime use per FDA label.
FDA-approved drug used for severe osteoporosis. Federations don't typically address it.
Approved as Forteo (2002) for severe osteoporosis in postmenopausal women, men with primary or hypogonadal osteoporosis, and glucocorticoid-induced osteoporosis.
Yes, endocrinology and rheumatology providers prescribe it for osteoporosis. ~24 months is the standard course; the FDA removed the hard 2-year lifetime cap in Nov 2020, so longer use is label-permitted if high fracture risk persists.
Who it's for
- →Severe osteoporosis under endocrine care
- →Stress-fracture recovery (off-label)
- →Older adults with high fracture risk
What to expect
- Week 1
Subtle. Some calcium-flux symptoms early.
- Week 4
Bone markers improving on labs.
- Week 8
Cumulative bone density gains over months, not weeks.
Looking at Teriparatide? Your next 3 steps
- 1Work out your exact dose
Vial size + BAC water turns into the exact units to draw for Teriparatide.
Open calculator → - 2See what to stack & monitor
The companion supplements and the bloodwork worth tracking on this kind of protocol.
Bloodwork guide → - 3Save it & ask the Coach
A free account saves your stack; membership adds the stack-aware AI Coach.
Create free account →
How it works (mechanism)
Recombinant first 34 amino acids of parathyroid hormone (PTH 1-34). Intermittent daily dosing favors osteoblast activity over osteoclast activity, building new bone, opposite of bisphosphonates which slow bone breakdown.
Dosing protocol
Stacks well with
Side effects
When NOT to use
- ⚠Paget's disease
- ⚠Prior radiation to bone
- ⚠Hypercalcemia
- ⚠Active malignancy
- ⚠Pregnancy / nursing
Bloodwork to monitor
- • Serum calcium baseline + at 1 month + every 6 months
- • 25-OH vitamin D
Common mistakes
- • Continuing past ~2 years without an ongoing high-fracture-risk reason (the hard lifetime cap was removed in 2020)
- • Skipping calcium / vitamin D adequacy first
- • Underestimating the prescription-and-monitoring requirement
Drug & supplement interactions
- ⚠Digitalis (digoxin): teriparatide-induced calcium fluctuations may sensitize to digitalis effects
- ⚠Thiazide diuretics: may cause hypercalcemia
- ⚠Standard ~2-year course (the hard 24-month lifetime cap was removed in 2020), combine with calcium and vitamin D adequacy
New to Teriparatide? Grab the starter checklist.
Drop your email and we'll send the one-page first-cycle starter checklist, plus a heads-up if Teriparatide changes legal status. No account needed.
No spam. No selling your email. Just the checklist and the occasional reclassification alert.
Ask the Coach anything about Teriparatide or your own stack. This is it working.
Trained only on Pepdex content. Does the dose math, flags interactions, knows your stack. Won't push vendors, won't pretend to be a doctor.
Get the Coach, $7.99/mo →Frequently asked
What is Teriparatide?+
Is Teriparatide FDA approved?+
Is Teriparatide legal?+
Is Teriparatide banned by WADA?+
Are you still natty after taking Teriparatide?+
Do doctors prescribe Teriparatide?+
What's the typical dose of Teriparatide?+
What are the side effects of Teriparatide?+
How long until Teriparatide starts working?+
What can you stack with Teriparatide?+
Where do people get Teriparatide?+
More in Healing
Synthetic peptide derived from a stomach protein. Used to speed up tendon, ligament, and gut healing.
A fragment of Thymosin Beta-4. Drives cell migration and tissue repair, used for chronic soft-tissue stuff.
A compound studied for calming nerve pain and inflammation without raising red blood cells. An EPO-derived peptide that targets the innate-repair receptor without the red-blood-cell side of erythropoietin, studied for neuropathic pain, sarcoidosis, and diabetic complications.
A gut drug that helps people with short bowel syndrome absorb more nutrients. A recombinant GLP-2 analog, FDA-approved in 2012 for short bowel syndrome with intestinal failure; it hits a different receptor and indication than the GLP-1 weight-loss drugs.